Twice-a-year-PReP will only fulfill its potential if Medicaid takes decisive action to ensure it is accessible to the ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced ...

Hair care encompasses many practices, but they often call for high-quality products that cost mammoth sums. Though these ...

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated ...

In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates ...

The trial results indicated minimal adverse events and no evidence of immune-mediated clearance following TX45 treatment.

Now, new research suggests that yoga and other exercise regimens might work just as well to control these bladder issues.

The decision to discontinue BTK inhibitor treatment for CLL is complex, with emerging data suggesting that time-limited ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

During a Case-Based Roundtable® event, Samer A. Al'Hadidi, MD, MS, discussed the CARTITUDE-4 trial of cilta-cel in patients ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Lee has won other recognitions, including previous Orange County Register Best of OC awards, Castle Connolly Top Doctor, ...